X

Vous n'êtes pas connecté

Rubriques :

Maroc Maroc - THEMARKETHERALD.CA - A La Une - 16/Sep 17:41

FDA extends review period for Medexus’ treosulfan to 2025

Medexus Pharmaceuticals (TSX:MDP) reveals the U.S. FDA has extended the review period for the company's new drug application for treosulfan.

Articles similaires

Sorry! Image not available at this time

Ionis Announces FDA Acceptance of New Drug Application for Donidalorsen for Prophylactic Treatment of HAE

drugs.com - 04/Nov 23:11

CARLSBAD, Calif., Nov. 4, 2024 /PRNewswire/ -- Ionis Pharmaceuticals, Inc. (Nasdaq: IONS) announced today that the U.S. Food and Drug Administration...

Sorry! Image not available at this time

PTC Therapeutics Announces FDA Acceptance of Translarna NDA Resubmission

drugs.com - 30/Oct 05:10

WARREN, N.J., Oct. 30, 2024 /PRNewswire/ -- PTC Therapeutics, Inc. (NASDAQ: PTCT) announced today the U.S. Food and Drug Administration (FDA) has...

Sorry! Image not available at this time

FDA Approves Orlynvah (sulopenem etzadroxil and probenecid) for the Treatment of Uncomplicated Urinary Tract Infections

drugs.com - 25/Oct 21:10

DUBLIN and CHICAGO, Oct. 25, 2024 (GLOBE NEWSWIRE) -- Iterum Therapeutics plc (Nasdaq: ITRM) (Iterum), today announced that the U.S. Food and Drug...

Sorry! Image not available at this time

Abeona Therapeutics Completes Pz-cel Biologics License Application Resubmission to U.S. Food and Drug Administration

drugs.com - 29/Oct 22:10

CLEVELAND, Oct. 29, 2024 (GLOBE NEWSWIRE) -- Abeona Therapeutics Inc. (Nasdaq: ABEO) today announced that the Company has resubmitted its Biologics...

Sorry! Image not available at this time

Lexicon Announces Outcome of FDA Advisory Committee for Zynquista (sotagliflozin) as an Adjunct to Insulin Therapy for Glycemic Control in Adults with Type 1 Diabetes and Chronic Kidney Disease

drugs.com - 31/Oct 21:10

THE WOODLANDS, Texas, October 31, 2024 -- Lexicon Pharmaceuticals, Inc. (Nasdaq: LXRX) today announced the outcome of the U.S. Food and Drug...

Sorry! Image not available at this time

GATE 2025 application correction window deadline extended: Check new date here

times of india - 02/Nov 08:37

IIT Roorkee has extended the GATE 2025 application correction window to November 10, 2024, from its initial closure date of November 6. Registered...

Sorry! Image not available at this time

GATE 2025 application correction window deadline extended: Check new date here

times of india - 02/Nov 08:37

IIT Roorkee has extended the GATE 2025 application correction window to November 10, 2024, from its initial closure date of November 6. Registered...

Sorry! Image not available at this time

Odisha Police Recruitment 2024: Registration deadline extended, check new date and direct link to apply

times of india - 30/Oct 06:43

The Odisha Police's State Selection Board (SSB) has extended the registration deadline for the recruitment exam to November 15, 2024, to fill 2,080...

Sorry! Image not available at this time

FDA Grants Rare Pediatric Disease Designation to Omeros’ MASP-3 Inhibitor Zaltenibart for Treatment of C3 Glomerulopathy

drugs.com - 24/Oct 23:10

SEATTLE--(BUSINESS WIRE)--Oct. 24, 2024-- Omeros Corporation today announced that zaltenibart (OMS906) has received rare pediatric disease designation...

Sorry! Image not available at this time

Shorla Oncology Announces U.S. FDA Expanded Approval of Jylamvo (methotrexate), an Oncology and Autoimmune Drug for Pediatric Indications

drugs.com - 29/Oct 10:10

CAMBRIDGE, Mass.--(BUSINESS WIRE) October 29, 2024 --Shorla Oncology (‘Shorla’), a U.S.-Ireland specialty pharmaceutical company,...

Les derniers communiqués